Showing results (11-20 of 46) with videos related to
Sort By:
Pageof 5
Chemmedchem|May 4, 2010
The role of fluorine substitution in biphenyl methylene imidazole-type CYP17 inhibitors for the treatment of prostate carcinomaQingzhong Hu, Matthias Negri, Sureyya Olgen, et al.European Journal of Medicinal Chemistry|April 16, 2015
Identification of 4-(4-nitro-2-phenethoxyphenyl)pyridine as a promising new lead for discovering inhibitors of both human and rat 11β-HydroxylaseQingzhong Hu, Jessica Kunde, Nina Hanke, et al.Journal of Medicinal Chemistry|June 17, 2010
Isopropylidene substitution increases activity and selectivity of biphenylmethylene 4-pyridine type CYP17 inhibitorsQingzhong Hu, Lina Yin, Carsten Jagusch, et al.Journal of Medicinal Chemistry|August 6, 2010
Replacement of imidazolyl by pyridyl in biphenylmethylenes results in selective CYP17 and dual CYP17/CYP11B1 inhibitors for the treatment of prostate cancerQingzhong Hu, Carsten Jagusch, Ulrike E Hille, et al.European Journal of Medicinal Chemistry|December 22, 2014
Heteroatom insertion into 3,4-dihydro-1H-quinolin-2-ones leads to potent and selective inhibitors of human and rat aldosterone synthaseCornelia M Grombein, Qingzhong Hu, Sabrina Rau, et al.Drug Discovery Today|January 7, 2023
Natural products in pursuing novel therapies of nonalcoholic fatty liver disease and steatohepatitisHaiyan Li, Ting Guan, Shi Qin, et al.Journal of Medicinal Chemistry|September 2, 2014
Potent 11β-hydroxylase inhibitors with inverse metabolic stability in human plasma and hepatic S9 fractions to promote wound healingWeixing Zhu, Qingzhong Hu, Nina Hanke, et al.Biochemical and Biophysical Research Communications|July 11, 2016
Specificity of anti-prostate cancer CYP17A1 inhibitors on androgen biosynthesisSameer S Udhane, Bernhard Dick, Qingzhong Hu, et al.Journal of Medicinal Chemistry|July 18, 2013
Highly potent and selective nonsteroidal dual inhibitors of CYP17/CYP11B2 for the treatment of prostate cancer to reduce risks of cardiovascular diseasesMariano A E Pinto-Bazurco Mendieta, Qingzhong Hu, Matthias Engel, et al.Journal of Medicinal Chemistry|July 14, 2012
Novel imidazol-1-ylmethyl substituted 1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-ones as potent and selective CYP11B1 inhibitors for the treatment of Cushing's syndromeLina Yin, Simon Lucas, Frauke Maurer, et al.Pageof 5